Another potential CIC target is ABCB5, a novel human multidrug resistance mediator recently shown to be expressed by cells of melanocytic lineage and additional cancers responsible for resistance to chemotherapy in vitro [22,23]. This evidence concerns the gene ABCB5 and cancer.